[go: up one dir, main page]

AR039253A1 - Asociacion de un antitrombotico y de aspirina - Google Patents

Asociacion de un antitrombotico y de aspirina

Info

Publication number
AR039253A1
AR039253A1 ARP030101180A ARP030101180A AR039253A1 AR 039253 A1 AR039253 A1 AR 039253A1 AR P030101180 A ARP030101180 A AR P030101180A AR P030101180 A ARP030101180 A AR P030101180A AR 039253 A1 AR039253 A1 AR 039253A1
Authority
AR
Argentina
Prior art keywords
association
anthrombotic
aspirine
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
ARP030101180A
Other languages
English (en)
Inventor
Gilbert Lavielle
Bernard Cimetiere
Marie-Odile Vallez
Tony Verbeuren
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AR039253A1 publication Critical patent/AR039253A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Reivindicación 1: Asociación del compuesto (A) de fórmula (1) eventualmente en forma de isómero óptico o de una de sus sales farmacéuticamente aceptables y de aspirina o de una de sus sales farmacéuticamente aceptables.
ARP030101180A 2002-04-05 2003-04-04 Asociacion de un antitrombotico y de aspirina AR039253A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0204222A FR2838057B1 (fr) 2002-04-05 2002-04-05 Nouvelle association d'un antithrombotique et d'aspirine

Publications (1)

Publication Number Publication Date
AR039253A1 true AR039253A1 (es) 2005-02-16

Family

ID=28052120

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030101180A AR039253A1 (es) 2002-04-05 2003-04-04 Asociacion de un antitrombotico y de aspirina

Country Status (27)

Country Link
US (1) US7618955B2 (es)
EP (1) EP1496884B1 (es)
JP (1) JP4065853B2 (es)
KR (1) KR100645143B1 (es)
CN (1) CN1297265C (es)
AR (1) AR039253A1 (es)
AT (1) ATE329591T1 (es)
AU (1) AU2003246774B2 (es)
BR (1) BR0309019A (es)
CA (1) CA2480697A1 (es)
CY (1) CY1105106T1 (es)
DE (1) DE60306133T2 (es)
DK (1) DK1496884T3 (es)
EA (1) EA006978B1 (es)
ES (1) ES2264533T3 (es)
FR (1) FR2838057B1 (es)
GE (1) GEP20074101B (es)
HK (1) HK1076034A1 (es)
MA (1) MA27114A1 (es)
MX (1) MXPA04009760A (es)
NO (1) NO20044700L (es)
NZ (1) NZ535430A (es)
PL (1) PL371620A1 (es)
PT (1) PT1496884E (es)
UA (1) UA79457C2 (es)
WO (1) WO2003084525A1 (es)
ZA (1) ZA200407593B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2615975C (en) * 2005-07-22 2012-11-27 The Procter & Gamble Company Compositions for reducing the incidence of drug induced arrhythmia
CN103071154A (zh) * 2007-04-13 2013-05-01 千年药品公司 用起因子xa抑制剂作用的化合物的组合抗凝治疗
JP2009001537A (ja) * 2007-06-25 2009-01-08 Lab Servier 血管障害の処置を目的とする医薬の入手における抗アテローム血栓化合物の使用
FR2920772B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
WO2003084525A1 (fr) 2003-10-16
EP1496884B1 (fr) 2006-06-14
AU2003246774A1 (en) 2003-10-20
HK1076034A1 (en) 2006-01-06
PT1496884E (pt) 2006-09-29
EA006978B1 (ru) 2006-06-30
EA200401293A1 (ru) 2005-02-24
CN1646111A (zh) 2005-07-27
PL371620A1 (en) 2005-06-27
MA27114A1 (fr) 2004-12-20
JP2005528376A (ja) 2005-09-22
DE60306133D1 (de) 2006-07-27
US20050143354A1 (en) 2005-06-30
GEP20074101B (en) 2007-05-10
CA2480697A1 (fr) 2003-10-16
UA79457C2 (en) 2007-06-25
US7618955B2 (en) 2009-11-17
DE60306133T2 (de) 2007-01-04
KR100645143B1 (ko) 2006-11-10
DK1496884T3 (da) 2006-10-02
AU2003246774B2 (en) 2007-02-15
NO20044700L (no) 2004-10-29
FR2838057A1 (fr) 2003-10-10
ATE329591T1 (de) 2006-07-15
KR20040098053A (ko) 2004-11-18
ES2264533T3 (es) 2007-01-01
ZA200407593B (en) 2006-07-26
NZ535430A (en) 2006-09-29
EP1496884A1 (fr) 2005-01-19
FR2838057B1 (fr) 2005-07-08
BR0309019A (pt) 2005-02-01
CY1105106T1 (el) 2009-11-04
CN1297265C (zh) 2007-01-31
JP4065853B2 (ja) 2008-03-26
MXPA04009760A (es) 2004-12-13

Similar Documents

Publication Publication Date Title
PA8561801A1 (es) Cis-imidazolinas
ES2545205T3 (es) Combinación de azelastina y ciclesonida
ATE456368T1 (de) Reboxetin enthaltende tablette mit verzögerter wirkstoffabgabe
DE60333020D1 (de) Anzeigeeinrichtung des dünnen typs
GB2388992B (en) Projector with narrow-spectrum light source to complement broad-spectrum light source
TR200200129T2 (tr) Hepatit C inhibitörü tri-peptidler
RS52274B (en) Diarzlhzdantoin compound
TR199901077A2 (en) �spen�iyari form�lasyonlar.
ATE481966T1 (de) Polyacrylfilm formende zubereitungen
NO20043004L (no) 4-oksokinolin forbindelse og anvendelse derav som HIV-integraseinhibitor
DE60323444D1 (de) Projektor
CR6682A (es) Inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorios, autoinmunes y respiratorias
EP1602971A4 (en) LIGHT SOURCE AND PROJECTOR THEREOF
DK1596870T4 (da) Højdosis-ibandronatformulering
EP1543950A4 (en) ITEMS IDENTIFYING MEDIUM WITH MULTILAYER THIN FILM
DE60225686D1 (de) Paracetamol enthaltende tablette
ATA8662002A (de) Fälschungssichere metallfolie
DE60326068D1 (de) Projektor
AR039253A1 (es) Asociacion de un antitrombotico y de aspirina
AR053989A1 (es) Compuestos espiro-hidantoina sustituidos con piridilo. composiciones farmaceuticas y procesos de obtencion.
AR045724A1 (es) Composicion farmaceutica orodispersable de un compuesto antitrombotico
ITMI20032431A1 (it) Procedimento per ingrandire il campo dell'immagine di una camera focal-plane-array.
UY27741A1 (es) Supositorios de meloxicam
IS7537A (is) Notkun á nýjum etónógestrel esterum.
CO5021190A1 (es) Agentes terapeuticos

Legal Events

Date Code Title Description
FB Suspension of granting procedure